Previous 10 | Next 10 |
2024-02-16 12:34:51 ET More on Viking Therapeutics Viking Therapeutics, Inc. (VKTX) Q4 2024 Earnings Call Transcript Evaluating Viking's Position In The GLP-1/GIP Agonist Race Biotech And Pharma Diversification Pays Off Viking Therapeutics GAAP EPS of -$0.25 ...
2024-02-16 10:29:22 ET More on Novartis Novartis And MorphoSys Are A Perfect Match Novartis AG (NVS) Q4 2023 Earnings Call Transcript Novartis AG 2023 Q4 - Results - Earnings Call Presentation MorphoSys ADRs gain after definitive merger agreement with Novarti...
2024-02-16 08:30:00 ET Summary Novo Nordisk investors have witnessed significant growth and outperformed the S&P 500, but the recent surge has led to considerable overvaluation. The company remains the market leader in the GLP-1 market, benefiting from the surge in demand amid...
2024-02-16 07:15:34 ET More on Eli Lilly Eli Lilly: Very Strong Fundamentals, But Market Is Euphoric Eli Lilly: Overvaluation Is A Big Red Flag Will Eli Lilly and Company Become A Trillion-Dollar Baby? Eli Lilly obesity therapy tirzepatide being rolled out in...
2024-02-15 14:03:45 ET Summary Eli Lilly's financial results for Q4 2023 showed a 28% increase in total revenue compared to the same period last year. The company's new launch, Zepbound, is expected to drive sales growth in 2024 and contribute to a projected revenue growth of 18-2...
2024-02-15 11:45:00 ET Today, just seven publicly listed companies are valued at a market cap of more than US$1 trillion. However, the widening GDP (gross domestic product) rates globally and expanding earnings base for corporates should drive valuations in the upcoming decade. Here...
A look at the top 10 most actives in the United States Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 6.3% to $4.3 on volume of 124,140,302 shares Treasure Global Inc. (TGL) rose 60.4% to $0.1588 on volume of 122,843,335 shares PROSHARES TRUST (SQQQ) fell 3.3% to $11.41 on volume...
2024-02-15 08:45:06 ET Palm Beach, FL – February 15, 2024 – FN Media Group News Commentary – Numerous reports indicate that the fibromyalgia treatment market is positioned to continue to grow at a substantial rate through the next decade. Fibromyalgia is a chronic c...
2024-02-15 07:53:06 ET More on Eli Lilly Eli Lilly: Overvaluation Is A Big Red Flag Will Eli Lilly and Company Become A Trillion-Dollar Baby? Eli Lilly and Company: Even 'Miracle Drugs' Can't Keep Stock Rising (Downgrade) Eli Lilly partner BioAge wins $170M t...
2024-02-14 17:35:57 ET Summary Novo Nordisk reported great results for fiscal 2023 with the top and bottom line growing in the higher double-digits. Growth was especially driven by Wegovy and Ozempic, and management is also optimistic for fiscal 2024. Novo Nordisk is trading f...
News, Short Squeeze, Breakout and More Instantly...
2024-07-29 09:20:00 ET While the market for anti-obesity medicines is characterized today by a fight between Novo Nordisk 's (NYSE: NVO) drug Wegovy and Eli Lilly 's (NYSE: LLY) drug Zepbound, that won't always be the case. Over the coming years, the competitive dynamics of ...
2024-07-29 07:30:00 ET When a major player announces good news in a lucrative market like weight loss drugs, it's often enough to drive shares of competitors down based on the assumption that they will have struggles ahead. That's just what happened after an announcement by Roche Hold...
2024-07-27 07:15:00 ET According to some research, bull markets tend to last an average of 2.6 years. The one we are currently experiencing has been going on for almost two years -- maybe it will soon end, maybe it won't. Equities that can perform well throughout bull runs might be good to ...